P4HB and neoplasm: Our results also provided a new insight for the research of HCC biomarkers and anti-tumor drug targets by using ECA-binding membrane CAT and P4HB glycoproteins, which is conducive to understanding HCC mechanisms and provides a set of potential targets for diagnostic application and therapeutic strategies.